Integra LifeSciences Holdings Corporation is a medical technology company that develops, manufactures, and markets products used in neurosurgery, regenerative medicine, and surgical reconstruction. The company’s current business is organized around two main segments, Codman Specialty Surgical and Tissue Technologies, which support procedures in neurosurgery, neurocritical care, otolaryngology, wound repair, and tissue reconstruction. Its portfolio includes surgical instruments, dural repair products, cerebrospinal fluid management devices, cranial stabilization tools, and regenerative tissue technologies designed for complex wound and reconstructive care. Integra LifeSciences Holdings Corporation serves hospitals, surgery centers, and specialist clinicians across a range of medical disciplines, making it an important supplier in the healthcare equipment market. Headquartered in Princeton, New Jersey, the company focuses on providing clinically oriented solutions for procedures that require precision, reliability, and specialized surgical support.
Website1100 Campus Road
Princeton, NJ, 08540
United States
Let’s dig into the relative performance of Integra LifeSciences (NASDAQ:IART) and its peers as we unravel the now-completed Q2 surgical equipment & consumables - specialty earnings season.
PRINCETON, N.J., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Lea Knight, chief financial officer, and Michael McBreen, chief commercial officer, will present at the 2026 Wells Fargo Healthcare Conference on Wednesday, September 9, 2026, at 2:15 p.m. ET. Stuart Essig, chairman and chief executive officer, will present at the 2026 Morgan Stanley Healthcare Conference on Tuesday, Septe
Detailed price information for Trupanion Inc (TRUP-Q) from The Globe and Mail including charting and trades.
Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Investors talking about IART also mention
| # | Name | Attention |
|---|---|---|
| 1 | Fortrea Holdings Inc.FTRE | 0%0 |
| 2 | Vestis CorporationVSTS | 0%new |
| 3 | Dianthus Therapeutics Inc.DNTH | 0%0 |
| 4 | Bruker CorpBRKR | 0%0 |
| 5 | Insight Enterprises, Inc.NSIT | 0%0 |
| 6 | Acadia Healthcare Company, Inc.ACHC | 0%new |
| 7 | CareDx IncCDNA | 0.01%+0.01 |
| 8 | UroGen Pharma Ltd.URGN | 0%new |
| 9 | Forte Biosciences, Inc.FBRX | 0%new |
| 10 | Travere Therapeutics Inc.TVTX | 0%0 |
What share of all stock conversation is about IART?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% 0 | 0% 0 | 0% 0 |
Of the messages about IART that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | — | — | 95.52% +28.38 | ||
| Bearish | — | — | — | 4.48% -28.38 |
Of the messages about IART that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | — | — | 42.61% | ||
| Technical Analysis | — | — | — | 27.83% | ||
| Analysts | — | — | — | 16.52% | ||
| Earnings | — | — | — | 7.83% | ||
| Controversies | — | — | — | 1.74% | ||
| Macro | — | — | — | 3.48% |
Of the messages about IART, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | — | — | — | 13.35% | ||
| Newcomers | — | — | — | 86.65% |